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Abstract 
 
1-Hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones, as a new type of 
azaheterocyclic hydroxamic acids, have been synthesized regioselectively from 1-
carbamoylmethyl- or 1-(methoxycarbonyl)methyl-2,3,3-trimethyl-3H-indolium salts by  
reaction with hydroxylamine in the presence of a strong base. The alkylation and reduction 
with sodium borohydride of these novel heterocycles have been investigated. When treated 
with protic acids 1-hydroxy- or 1-alkoxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones 
underwent ring opening of the imidazolidine to afford 1-[2-(hydroxyamino)-2-oxoethyl]-
2,3,3-trimethyl-3H-indolium salts. The structural assignments are based on extensive 
1
H, 
13
C 
and 
15
N NMR spectroscopic studies and single crystal X-ray analyses. 
 
1. Introduction 
 
1-Substituted 3H-indolium salts are important synthetic precursors in the preparation of 
functionalized organic dyes with wide technical and biomedical applications.
1
 Quaternisation 
of 2,3,3-trimethyl-3H-indole with 2-haloacetamides affords reactive 1-carbamoylmethyl-
2,3,3-trimethyl-3H-indolium salts,
2
 possessing several reactive centres, which allow them to 
participate in various chemical transformations. The reaction of the latter with squaric acid 
afforded squaraine dyes, which have been investigated as non-covalent protein probes with 
high fluorescence quantum yield and good photostability.
3
 When condensed with salicylic 
aldehydes, they underwent spirocyclization due to intramolecular addition of the phenolic 
oxygen atom across the carbon atom at the 2-position of the indole to give photochromic and 
thermochromic 1-carbamoylmethylindoline[2,2’]spirobenzopyrans.4 It is known also that 1-
carbamoylmethyl-2,3,3-trimethyl-3H-indolium chloride upon treatment with base undergoes 
cyclization to 9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones by nucleophilic addition of 
the amide nitrogen atom across the carbon atom at the 2-position of the indole.
2
 Furthermore, 
9a-styryl-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-one derivatives were designed as color 
formers for pressure- and heat-sensitive recording materials.
5
 Finally, reaction of 1-
carbamoylmethyl-3H-indolium chloride with hydrazine bishydrate selectively afforded 1-
amino-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones, possessing a cyclic hydrazide 
moiety, which was easily transformed to various heterocyclic structures.
6
 
In an effort to expand the chemical space of ring fused indoline derivatives bearing an 
annelated heterocycle at the N-1 ‒ C-2 bond of the indole nucleus, the objective of this work 
  3 
was to investigate the reaction of 1-carbamoylmethyl-2,3,3-trimethyl-3H-indolium salts with 
hydroxylamine, and the structure of the indolyl hydroxamic acid derivatives obtained. The 
targeted heterocyclic compounds contain a 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-
2(3H)-one core (Figure 1), which is, to the best of our knowledge, unreported in the literature. 
This new azaheterocyclic scaffold is however interesting in view of its similarity with the 
isomeric 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-3(2H)-one core which is present in 
the natural hydroxylamine alkaloids tryptoquivaline, possessing tremorgenic activity, and 
asperlicin B, which is a competitive cholecystokinin (CCK) antagonist (Figure 1).
7
 
Hydroxamic acids are versatile analytical reagents for the analysis and separation of metals
8
 
and possess also wide biomedical applications.
9
 More specifically, 5-bromo-1H-indole-3-
acetohydroxamic acid was recently identified as a potent inhibitor of bacterial deformylases 
(Figure 1),
10 
while 1H-indole-1-acetohydroxamic acid derivatives were used for the 
preparation of electroconductive polymer films.
11
 O-Alkylated hydroxamic acids are active 
inhibitors of lypogenase-mediated processes,
12
 while cyclic hydroxamic acids exhibit metal 
chelating abilities and various biological activities.
13
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2. Results and discussion 
 
It is known that a hydroxamic acid moiety can be easily introduced by treatment of amides 
with hydroxylamine at neutral or at alkaline pH,
14
 while the corresponding reaction with 
esters requires alkaline conditions (pH > 10).
15
 When 1-carbamoylmethyl-2,3,3-trimethyl-3H-
indolium chlorides 1 were heated with hydroxylamine hydrochloride in the presence of 
  4 
sodium hydroxide, selective formation of the 1-hydroxy-9,9,9a-trimethyl-9,9a-dihydro-1H-
imidazo[1,2-a]indol-2(3H)-ones 3 took place without any observation of the corresponding 
six-membered compounds 4. Similarly, 1-(methoxycarbonyl)methyl-3H-indolium perchlorate 
5, prepared by treatment of 2,3,3-trimethyl-3H-indole with methyl 2-bromoacetate,
16
 
efficiently reacted with hydroxylamine under basic conditions to afford the five-membered 
compound 3a (Scheme 1). 
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The formation of derivatives 3 likely proceeds through a mechanism that includes formation 
of the enamine intermediate 2 that undergoes cyclization to the tricyclic compound by 
intramolecular addition of the hydroxamic nitrogen across the electrophilic indole C-2 atom. 
Formation of cyclic hydroxamic acid derivatives by addition of the hydroxamic nitrogen 
across a triple bond has been reported earlier by Elguero et al.
17 
The structure of azaheterocyclic hydroxamic acids 3a-c was determined by microanalyses and 
spectral data. The IR spectrum of 3a showed absorption bands at 3110 and 1702 cm
-1
 
attributable to O-H and C=O groups, respectively. The 
15
NMR spectrum of 3a showed two 
different N-atoms with chemical shifts at –193.0 (N-1) and –298.6 (N-4) ppm. In 15N DEPT 
experiments without 
1
H-decoupling, the resonance signal (–193.0 ppm) of the N-1 atom of 3a  
appeared as a singlet, thus indicating the absence of an NH moiety. This definitely ruled out 
the corresponding six-membered structure 4, for which signals of a NH substructure and 
tertiary nitrogen atom would be expected. The assignments presented in Figure 2 were based 
on the combined application of standard NMR techniques such as NOE-difference (Figure 2b), 
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NOESY, APT, DEPT, HSQC, HMBC and long-range INEPT spectra with selective 
excitation.
18 
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Figure 2. (a) 
1
H NMR (italics), 
13
C NMR (plain) and 
15
N NMR (bold) chemical shifts [ppm; 
ref. TMS (
1
H
 
and 
13
C) and CH3NO2 (
15
N)] for 3a in DMSO-d6. (b) Relevant NOE correlations.  
 
The single crystal X-ray structure of 3a (Figure 3)
19
 shows that the skeleton of the asymmetric 
unit contains the imidazo[1,2-a]indole ring system, with the external hydroxy group attached 
to the atom N(1). The bond lengths, bond angles and dihedral angles are typical for the 
azaheterocyclic hydroxamic acid core and related to 1-hydroxy-1,3-imidazolidin-4-one.
20-22
  
 
    
                     
                               (a)                                                               (b)                                                      
 
Figure 3. (a) ORTEP drawing of 1-hydroxyimidazo[1,2-a]indol-2(3H)-one 3a. (b) Fragment 
of the heterochiral layer of the racemic crystals of 3a. 
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The packaging of the chiral molecules 3a into a racemic crystal occurs in such a way that 
mirror R- and S-enantiomers are self-assembled into alternate chiral chains of opposite 
chirality, which are connected by strong intermolecular O-H∙∙∙O=C type hydrogen bonds 
(Figure 3b).  
Hydroxamic acids are ambident nucleophiles. However, deprotonation of the OH group 
usually results in O-alkylation products. Leggio et al. used diazomethane as selective O-
alkylation agent of aliphatic hydroxamic acids.
23
 In that case diazomethane reacted as a base 
to deprotonate the hydroxamic acid, resulting in a methyldiazonium ion which selectively 
methylated the generated hydroxamate anions.
24
 The alkylation of hydroxamic acid 3a with 
trimethylsilyldiazomethane – a mild and efficient reagent used for the O-methylation of 
carboxylic acids and alcohols as a safer alternative for highly toxic and explosive 
diazomethane – was investigated.25 
Treatment of hydroxamic acid 3a with trimethylsilyldiazomethane in a mixture of benzene 
and methanol (3:1) at room temperature afforded 1-methoxy-1H-imidazo[1,2-a]indol-2(3H)-
one 6a in 71% yield after column chromatography (Scheme 2). O-Ethylation of compound 3a 
was easily achieved by reaction of hydroxamic acid 3a with triethyloxonium tetrafluoroborate, 
a reagent used for the selective alkylation of O-alkylarylhydroxamic acids,
26
 and gave 
compound 6b in 54% yield. Further experiments showed that the hydroxy functionality of 3a 
can be smoothly O-alkylated with methyl and ethyl iodide in the presence of potassium 
carbonate, providing the desired products 6a,b in 90% and 78% yield, respectively. The 
reaction with benzyl chloride resulted similarly in benzyl ether 6c in 66% yield (Scheme 2). 
The deprotonation of N-substituted lactams with a strong lithium base in THF, followed by 
reaction of the formed enolates with haloalkanes is known to lead to α-C-alkylated lactams.27 
However, treatment of compounds 6 possessing the N-(alkyloxy)lactam moiety, with n-BuLi 
in THF followed by addition of iodomethane afforded exclusively the O-methylated products 
7. The structure of the latter was confirmed by the presence of a singlet of H-3 in the range of 
4.98-5.16 ppm in the 
1
H NMR spectra and a signal of C-3 at ~89.0 ppm in the 
13
C NMR 
spectra (CDCl3). 
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Under the influence of strong protic acids 9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones 
undergo imidazolidine ring opening and are converted to 1-carbamoylmethyl-3H-indolium 
salts.
2
 When the ethanolic solution of 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-
one 3a was treated with perchloric acid in ethanol at 5 °C for 16 h, formation of 1-[2-
(hydroxyamino)-2-oxoethyl]-2,3,3-trimethyl-3H-indolium perchlorate (8a) took place 
(Scheme 3). X-ray diffraction analysis of the crystal structure of 8a revealed the presence of 
the tautomeric keto form and Z-configuration of the hydroxamic acid moiety (Figure 4).
28 
Nevertheless, the 
1
H and 
13
C NMR spectra of perchlorate 8a at room temperature (20 °C) in 
TFA-d exhibited two sets of resonance signals. The appearance of signals at 203.39 and 
203.43 ppm in the 
13
C NMR spectrum, was indicative of a N
+
=C carbon. The 
1
H NMR 
spectrum of 8a contained signals at 1.69 (non-resolved signals of 3,3-CH3), 2.86 and 2.90 
(minor and major peaks of 2-CH3, respectively), 5.49 and 5.78 ppm (major and minor peaks of 
CH2, respectively), with a 7:3 ratio of the major and minor isomers. The analogous 
1
H and 
13
C 
NMR spectra obtained from the solution of 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-
2(3H)-one 3a in TFA-d demonstrated the cleavage of the imidazolidine ring with formation of 
the corresponding 3H-indolium cations. 
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Theoretically, hydroxamic acids can exist in solution as an equilibrium mixture of the two 
tautomers: RC(=O)NHOH (I)  RC(OH)=NOH (II), where (I) is the hydroxamide (or 
hydroxamic acid) form, and (II) the hydroxyimine form.
29 
As such, structural complications of 
hydroxamic acids can occur due to different conformations of the C-N bond of the 
hydroxamic tautomer and, as well, different configurations of the C=N bond of the 
hydroximic form. Nevertheless, recent NMR structural investigations of hydroxamic acids 
(for example of 
15
N-enriched dihydroxamic acids in solutions of DMSO) showed that 
hydroximic forms of the acids are not present in a detectable amount.
30
 It was established by 
Brown et al.
 
that acetoxyhydroxamic acids are present in DMSO solutions as an equilibrium 
mixture of Z and E conformers with the Z-conformer prevailing.
31 
In the solid state, 
acetohydroxamic acid hemihydrate exists as the Z-isomer only.
32
 Most secondary hydroxamic 
acids, except N-aryl derivatives, in turn, exist as E conformers.
33
 Therefore, the presence of 
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two sets of signals in the NMR spectra of perchlorate 8 in TFA-d can be rationalized by the 
formation of an equilibrium mixture of isomeric salts 8a and 8b possessing a different 
geometry (Z or E) of the hydroxamic acid moiety (Scheme 3). Neutralization of the 
perchlorate 8 with a solution of sodium carbonate gave the starting tricyclic compound 3a 
only. 
 
 
 
Figure 4. Crystal structure of perchlorate 8a showing the most significant intermolecular 
interactions  
 
Analogously, the 
1
H and 
13
C NMR spectra of 1-methoxy-9,9a-dihydro-1H-imidazo[1,2-
a]indol-2(3H)-one 6a in TFA-d at room temperature (20 °C) exhibited two sets of peaks, 
which can be attributed to the Z- and E-cations 10a and 10b. The 
1
H NMR spectrum 
contained the singlets of the 2-CH3 group at 3.89 ppm (major isomer) and 4.06 ppm (minor 
isomer), and the singlets of the CH2CO group at 5.40 ppm (major isomer) and 5.65 ppm 
(minor isomer), with a 5:2 ratio of the major/minor isomer. The corresponding 
13
C NMR 
spectrum showed the characteristic carbon signal of the 
+
N=C moiety at 201.4 ppm.  
It is known that hydroxamic acids are more stable in basic medium than in acidic medium. 
The products resulting from their acidic hydrolysis usually are hydroxylamine and the parent 
carboxylic acid.
34
 Prolonged storage of the solution of 1-hydroxy-9,9a-dihydro-1H-
imidazo[1,2-a]indol-2(3H)-one 3 in ethanol, containing water and HBF4, at 5 ºC, afforded 
crystalline 1-carboxymethyl-3H-indolium tetrafluoroborate monohydrate 11 (Scheme 3). In 
contrast to the 1-[2-(hydroxyamino)-2-oxoethyl]-2,3,3-trimethyl-3H-indolium perchlorate 
(8a), the NMR spectra of tetrafluoroborate 11 in TFA-d contains only one set of signals. In 
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the 
13
C NMR spectrum, the characteristic carbon signal of the 
+
N=C moiety is present at 
203.3 ppm.  
The single crystal X-ray analysis of tetrafluoroborate 11 discloses that a molecule of 
crystallization water is present in the crystal lattice which bridges the oxygen of the carboxyl 
group and the BF4
- 
anion via hydrogen bonding (Figure 5a). The crystal structure is assembled 
from hydrogen-bonded dimers (Figure 5b).
35
 
 
         
                        (a)                                                                        (b) 
Figure 5. (a) Crystal structure of tetrafluoroborate monohydrate 11 showing the most 
significant intermolecular interactions. (b) Hydrogen-bonded dimer of 11  
 
It has been reported recently that 1-amino-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones 
smoothly underwent reductive ring opening upon treatment with NaBH4 in ethanol to give 1-
substituted 2,3-dihydro-1H-indole derivatives.
6
 When 1-hydroxy-9,9a-dihydro-1H-
imidazo[1,2-a]indol-2(3H)-one 3a was reacted under similar reducing conditions, the 
expected reaction did not occur and most of the starting material was recovered unchanged. 
However, transformation of cyclic hydroxamic acid 3a to the reduced compound 12 was 
easily achieved by treatment with NaBH4 in glacial acetic acid as solvent instead of ethanol 
(Scheme 3). It can be assumed that in the first step of this reductive ring opening, acetic acid 
promotes cleavage of the annelated lactam moiety leading to the formation of the 
corresponding 1-[2-(hydroxyamino)-2-oxoethyl]-3H-indolium acetate. Subsequently, in situ 
generated acetoxyborohydride
36,37 
smoothly reduces the iminium group to afford indoline 12.
 
The structure of 1-[2-(hydroxyamino)-2-oxoethyl]-2,3,3-trimethylindoline 12 was confirmed 
by the presence of characteristic signals of the CHCH3 moiety, consisting of a doublet at 1.26 
ppm and a quadruplet at 3.15 ppm, in the 
1
H NMR spectrum (CDCl3). The 
1
H NMR spectrum 
  11 
exhibited only one set of signals attributed to the more stable Z-isomer form in accordance 
with literature data.
32-34
 
After having explored the reactivity of 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-
2(3H)-ones, it was decided also to explore the chemistry of the corresponding known N-
methylated compound 13 in more detail.
4d
 It is interesting to note that the 
1
H NMR spectrum 
of the cyclic lactam 13 in TFA-d, possessing the methyl group at the nitrogen atom N-1 
exhibited, as it was expected, only one set of signals, including the characteristic singlets at 
1.44 [3,3-(CH3)2], 2.61 (N
2
HCH3), 2.76 (2-CH3) and 5.14 ppm (CH2) corresponding with the 
formation of the ring opened cation Z-14 (Scheme 4). It is known that N-substituted amides 
exist in solution generally as the Z-conformers, and only in the case of N-methylacetamide the 
E-conformer was found experimentally to occur in a low population of 1.5% besides the 
prevailing Z-conformer.
38
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Figure 6. (a) 
1
H NMR (italics), 
13
C NMR (plain) and 
15
N NMR (bold) chemical shifts [ppm; 
ref. TMS (
1
H
 
and 
13
C) and CH3NO2 (
15
N)] for 15 in CDCl3. (b) Relevant NOE correlations 
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The methylation of lactam 13 via formation of the corresponding lithium enolate was next 
evaluated. It was found that the deprotonation of 13 with n-BuLi at –78 °C in THF, and 
subsequent alkylation by treatment with iodomethane proceeded diastereoselectively to afford 
C-3-methylated lactam 15. The structure and stereochemistry of lactam 15 was confirmed by 
methods of NMR spectroscopy (Figure 6a, b). The assignments presented in Figures 6a,b 
were based on the combined application of standard NMR techniques such as NOE-
difference, NOESY, APT, DEPT, HSQC, HMBC and long-range INEPT spectra with 
selective excitation.
18
 The 
1
H NMR spectrum of substituted lactam 15 contained a doublet at 
1.56 ppm (J = 6.9 Hz) and a quadruplet at 3.78 ppm characteristic for the CH3CH moiety. The 
NOE experiments (NOESY, NOE-difference) of compound 15 revealed a through-space 
interaction between H-3 (3.78 ppm) and the 9-CH3 group resonating at 1.01 ppm, but no 
interaction between H-3 and 9a-CH3 (1.426 ppm). On the other hand, both geminal CH3 
groups at C-9 were easily identified on the basis of NOE’s with aromatic ring proton H-8 and 
via HMBC (correlation to C-8a). These observations indicate that compound 15 corresponds 
to the structure possessing the (3R*,9aS*)-relative configuration. Molecular modelling
39
 
confirmed that in the latter case H-3 and the 9-CH3 group occupy a spatial orientation for 
which the observed NOE effects are expected, while (3R*,9aR*)-relative configuration would 
lead to interaction of H-3 with the 9a-CH3. 
 
3. Conclusion 
 
1-Carbamoylmethyl- and 1-(methoxycarbonyl)methyl-3H-indolium salts 1 and 5, 
respectively, are regioselectively cyclized into five-membered ring compounds, as new 
azaheterocyclic hydroxamic acids, that is, 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-
2(3H)-ones 3. Alkylation of 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones 
with trimethylsilyldiazomethane, triethyloxonium tetrafluoroborate or haloalkanes in the 
presence of base gave exclusively O-substituted products 6a-c. The action of strong protic 
acids on 1-hydroxy-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-ones causes opening of the 
imidazolidine ring, annelated to indole system, to afford 1-[2-(hydroxyamino)-2-oxoethyl]-
3H-indolium salts 10, 11, while treatment with sodium borohydride in acetic acid led to 
reductive ring opening with formation of N-hydroxy-2-(2,3,3-trimethyl-2,3-dihydro-1H-indol-
1-yl)acetamide 12. 
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4. Experimental 
 
4.1. General 
 
The melting points were determined in open capillary tubes on a Büchi B-540 melting point 
apparatus and are uncorrected. Infrared spectra were recorded with a Perkin Elmer Spectrum 
One spectrometer using potassium bromide pellets. 
1
H NMR spectra were recorded at 300 
MHz on a Varian Unity Inova spectrometer and at 500 MHz on a Bruker Avance 500 
spectrometer; 
13
C NMR spectra were registered at 75 and 125 MHz, respectively. Chemical 
shifts, expressed in ppm, were relative to tetramethylsilane (TMS). 
15
N NMR spectra (50.69 
MHz) were obtained on a Bruker Avance 500 spectrometer using a ‘directly’ detecting 
broadband observe probe and were referenced against neat, external nitromethane (coaxial 
capillary). Mass spectra were measured using a Waters ZQ instrument (ion spray). Diffraction 
data were collected on a Bruker-Nonius KappaCCD difractometer at room temperature and 
also at –100 °C. The crystal structures were solved using known programs.40 Elemental 
analyses were conducted using a Elemental Analyzer CE-440 (Exeter Analytical, Inc.)  by the 
Microanalytical Laboratory, Department of Organic Chemistry, Kaunas University of 
Technology. For thin layer chromatographic (TLC) analyses, Merck precoated TLC plates 
(silica gel 60 F254) were used. Dry THF was distilled from sodium and benzophenone. 
 
4.2. Procedures for preparation of 1-hydroxy-9,9,9a-trimethyl-9,9a-dihydro-1H-
imidazo[1,2-a]indol-2(3H)-ones (3) 
 
4.2.1. 1-Hydroxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-one (3a) 
Method A: To a solution of chloride 1a (3.79 g, 15 mmol) in dry methanol (20 mL) 
hydroxylamine hydrochloride (3.13 g, 45 mmol) and powdered sodium hydroxide (2.40 g, 60 
mmol) were added and the mixture was refluxed for 0.5 h. The insolubles formed were 
removed by filtration and the filtrate was concentrated under reduced pressure. The residue 
was purified by column chromatography on silica gel with hexane/EtOAc (2:1 v/v) as eluent 
to give 3a (2.98 g, 86%) as colourless crystals. Mp 168-169 °C (from EtOH).
 1
H NMR (500 
MHz, DMSO-d6): δ 1.10 (s, 3H, 9-CH3), 1.43 (s, 3H, 9-CH3), 1.45 (s, 3H, 9a-CH3), 3.84 (s, 
2H, CH2), 6.83-6.94 (m, 2H, 5-H, 7-H), 7.07-7.13 (m, 2H, 6-H, 8-H), 9.45 (s, 1H, OH). 
13
C 
NMR (125 MHz, DMSO-d6): δ 15.7 (9a-CH3), 22.4 (9-CH3), 27.3 (9-CH3), 47.0 (C-9), 50.9 
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(C-3), 92.5 (C-9a), 111.5 (C-5), 121.5 (C-7), 122.1 (C-8), 127.4 (C-6), 138.7 (C-8a), 150.8 
(C-4a), 171.9 (C=O). 
15
N NMR (50.69 MHz, DMSO-d6):  -193.0 (N-1), -298.6 (N-4). IR 
(KBr, cm
-1
): OH = 3110, C=O = 1702. MS (ES+) m/z (%): 233 (M + H
+
, 100). Anal. Calcd. 
for C13H16N2O2: C, 67.22; H, 6.94; N, 12.06. Found: C, 66.95; H, 6.68; N, 12.33. 
Method B: A mixture of 2,3,3-trimethyl-3H-indole (2.39 g, 15 mmol), methyl 2-bromoacetate 
(2.29 g, 15 mmol) and o-xylene (5 mL) was heated at 70 °C for 5 h and then left to reach 
ambient temperature. The solvent was decanted, the residue was dissolved in ethanol (8 mL), 
perchloric acid (70%) was added to pH 1 and the mixture was kept at 5 °C for 16 h. Crystals 
formed were filtered and recrystallized from ethanol to yield perchlorate 5 (2.24 g, 45%), mp 
172-174 °C (with decomposition). The obtained perchlorate 5 (1.66 g, 5 mmol) was dissolved 
in dry methanol (8 mL), hydroxylamine hydrochloride (1.04 g, 15 mmol) and powdered 
sodium hydroxide (0.8 g, 20 mmol) were added and the mixure was refluxed for 0.5 h. The 
insolubles formed were removed by filtration and the filtrate was concentrated under reduced 
pressure. The residue was purified by column chromatography on silica gel with 
hexane/EtOAc (2:1 v/v) as eluent to give 3a (0.85 g, 73%). Mp and NMR spectroscopy data 
of the title product 3a were identical with those obtained by Method A. 
 
4.2.2. 1-Hydroxy-7,9,9,9a-tetramethyl-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-one (3b)  
Similar treatment (Method A) of chloride 1b (1.33 g, 5 mmol) with hydroxylamine 
hydrochloride (1.04 g, 15 mmol) in the presence sodium hydroxide (0.8 g, 20 mmol) gave the 
title compound 3b (0.95 g, 77%) as colourless crystals, mp 161-162 °C (from EtOH). 
1
H 
NMR (300 MHz, DMSO-d6): δ 1.08 (s, 3H, 9-CH3), 1.40 (s, 3H, 9-CH3), 1.42 (s, 3H, 9a-CH3), 
2.22 (s, 3H, 7-CH3), 3.79 (s, 2H, CH2), 6.73 (d, J=7.8 Hz, 1H, 5-H), 6.89-6.92 (m, 2H, 6-H, 8-
H), 9.44 (s, 1H, OH). 
13
C NMR (75 MHz, DMSO-d6): δ 15.9 (9a-CH3), 20.6 (9-CH3), 22.2 (7-
CH3), 27.3 (9-CH3), 46.9 (C-9), 50.9 (C-3), 92.7 (C-9a), 111.2, 122.7, 127.7, 130.3, 138.7, 
148.5, 172.0 (C=O). IR (KBr, cm
-1
): OH = 3111, C=O = 1702. MS (ES+) m/z (%): 247 (M + 
H
+
, 20), 269 (M + Na
+
, 100). Anal. Calcd. for C14H18N2O2: C, 68.27; H, 7.37; N, 11.37. 
Found: C, 68.47; H, 7.53; N, 11.35. 
 
4.2.3. 7-Bromo-1-hydroxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-one 
(3c)  
Similar treatment (Method A) of chloride 1c (1.66 g, 5 mmol) with hydroxylamine 
hydrochloride (1.04 g, 15 mmol) in the presence sodium hydroxide (0.8 g, 20 mmol) gave the 
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title compound 3c (0.73 g, 47%) as colourless crystals, mp 186-187 °C (from EtOH). 
1
H 
NMR (300 MHz, DMSO-d6): δ 1.11 (s, 3H, 9-CH3), 1.41 (s, 3H, 9-CH3), 1.42 (s, 3H, 9a-CH3), 
3.85 (s, 2H, CH2), 6.85 (d, J=8.1 Hz, 1H, 5-H), 7.26 (dd, J=8.1 Hz, J=2.1 Hz, 1H, 6-H), 7.32 
(d, J=2.1 Hz, 8-H), 9.44 (s, 1H, OH). 
13
C NMR (75 MHz, DMSO-d6): δ 15.8 (9a-CH3), 22.0 
(9-CH3), 27.0 (9-CH3), 47.2 (C-9), 50.8 (C-3), 92.7 (C-9a), 111.8, 113.5, 125.2, 130.0, 141.5, 
150.1, 171.9 (C=O). IR (KBr, cm
-1
): OH = 3138, C=O = 1704. MS (ES+) m/z (%): 313/315 
(M + H
+
, 100). Anal. Calcd. for C13H15BrN2O2: C, 50.18; H, 4.86; N, 9.00. Found: C, 50.46; 
H. 4.97; N, 9.02. 
 
4.3. Procedures for preparation of 1-alkoxy-9,9,9a-trimethyl-9,9a-dihydro-1H-
imidazo[1,2-a]indol-2(3H)-ones (6) 
 
4.3.1. 1-Methoxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-one (6a) 
Method A: To a solution of compound 3a (100 mg, 0.43 mmol) in 4 mL of benzene/methanol 
(3:1 v/v) 2.0 M solution of trimethylsilyldiazomethane in Et2O (0.54 mL, 1.08 mmol) was 
added dropwise and the reaction mixture was stirred for 4 h at room temperature. Then the 
solvent was evaporated under reduced pressure, the residue dissolved in Et2O (4 mL) and the 
solution was washed with water (5 mL). The organic layer was separated and the aqueous 
layer was extracted with another 5 mL of Et2O. The combined organic layers were dried over 
MgSO4 and filtered. The solvent was evaporated under reduced pressure and the product was 
isolated by flash chromatography on a silica gel column using hexane/EtOAc (3:1 v/v) as 
eluent to give the title compound 6a (75 mg, 71%) as colorless crystals, mp 89-90 °C (from 
EtOH). 
1
H NMR (300 MHz, CDCl3): δ 1.21 (s, 3H, CH3), 1.50 (s, 3H, CH3), 1.53 (s, 3H, 
CH3), 3.81 (AB-d, J=17.0 Hz, 1H, 3-HA), 3.83 (AB-d, J=17.0 Hz, 1H, 3-HB), 3.84 (s, 3H, 
CH3O), 6.71-7.20 (m, 4H, Ar-H). 
13
C NMR (75 MHz, CDCl3): δ 17.0 (CH3), 22.6 (CH3), 27.4 
(CH3), 47.0 (C-9), 51.3 (C-3), 62.4 (OCH3), 93.8 (C-9a), 111.3, 122.1, 122.3, 127.8, 138.6, 
150.2 (Ar-C), 175.2 (C=O). IR (KBr, cm
-1
): C=O = 1748. MS (ES+) m/z (%): 247 (M+H
+
, 
100), 269 (M+Na
+
, 60). Anal. Calcd. for C14H18N2O2: C, 68.27; H, 7.37; N, 11.37. Found: C, 
67.89; H, 7.26; N, 11.13. 
Method B: To a solution of compound 3a (465 mg, 2 mmol) in DMF (5 mL), K2CO3 (304 mg, 
2.2 mmol) was added and the mixture was stirred for 15 min. Then methyl iodide (0.15 mL, 
0.34 g, 2.4 mmol) was added to the mixture and stirring was continued for 16 h. The reaction 
mixture was poured into water (15 mL), extracted with EtOAc (3×15 mL), the combined 
organic layers were dried over Na2SO4 and filtered. The solvent was evaporated under 
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reduced pressure and the product was isolated by chromatography on a silica gel column 
using hexane/EtOAc as eluent (3:1 v/v) to give the compound 6a (0.44 g, 90%). Mp and 
NMR spectroscopy data of the title product 6a were identical with those obtained by Method 
A. 
 
4.3.2. 1-Ethoxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-one (6b)  
Method A: To a solution of compound 3a (100 mg, 0.43 mmol) in dichloromethane (3 mL), 
triethyloxonium tetrafluoroborate (106 mg, 0.56 mmol) was added and the reaction mixture 
was stirred for 18 h at room temperature. Then the mixture was washed with water (5 mL), 
dried over MgSO4 and filtered. The solvent was evaporated under reduced pressure and the 
product was isolated by chromatography on a silica gel column using hexane/EtOAc (4:1 v/v) 
as eluent to give the title compound 6b as colorless oil (60 mg, 54%). 
1
H NMR (300 MHz, 
CDCl3): δ
 
1.21 (s, 3H, CH3), 1.24 (t, J=7.2 Hz, 3H, CH2CH3), 1.49 (s, 3H, CH3), 1.55 (s, 3H, 
CH3), 3.80 (AB-d, J=16.8 Hz, 1H, 3-HA), 3.83 (AB-d, J=16.8 Hz, 1H, 3-HB), 3.83-3.91 (m, 
1H, OCH2), 4.33 (dq, J=8.4, J=7.2 Hz, 1H, OCH2), 6.71-7.20 (m, 4H, Ar-H). 
13
C NMR (75 
MHz, CDCl3): δ 13.6 (CH3), 17.2 (CH3), 22.5 (CH3), 27.4 (CH3), 47.1 (C-9), 51.5 (C-3), 70.5 
(OCH2), 93.7 (C-9a), 111.4, 122.1, 122.2, 127.8, 138.8, 150.3 (Ar-C), 174.7 (C=O). IR (KBr, 
cm
-1
): C=O = 1739. MS (ES+) m/z (%): 261 (M+H
+
, 100), 283 (M+Na
+
, 60). Anal. Calcd. for 
C15H20N2O2: C, 69.20; H, 7.74; N, 10.76. Found: C, 68.89; H, 7.26; N, 10.36. 
Method B: The procedure for the synthesis of 6a (Method B) was followed using compound 
3a (465 mg, 2 mmol), K2CO3 (304 mg, 2.2 mmol) and ethyl iodide (0.192 mL, 374 mg, 2.4 
mmol) at room temperature for 16 h to give 6b (405 mg, 78%). NMR spectroscopy data of the 
title product 6b were identical with those obtained by Method A. 
 
4.3.3. 1-Benzyloxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indol-2(3H)-one (6c) 
The procedure for the synthesis of 6a (Method B) was followed using compound 3a (465 mg, 
2 mmol), K2CO3 (304 mg, 2.2 mmol) and benzyl chloride (0.335 mL, 304 mg, 2.4 mmol) at 
room temperature for 16 h to give 6c as colorless crystals (425 mg, 66%), mp 86-87 °C (from 
EtOH). 
1
H NMR (300 MHz, CDCl3): δ 1.23 (s, 3H, CH3), 1.56 (s, 3H, CH3), 1.60 (s, 3H, 
CH3), 3.89 (s, 2H, NCH2), 4.83 (d, J=9.0 Hz, 1H, OCH2), 5.33 (d, J=9.0 Hz, d, 1H, OCH2), 
6.75-7.46 (m, 9H, Ar-H). 
13
C NMR (75 MHz, CDCl3): δ 17.2 (CH3), 23.1 (CH3), 27.4 (CH3), 
47.2 (C-9), 51.4 (C-3), 76.2 (OCH2), 94.0 (C-9a), 111.3, 122.1, 122.3, 127.8, 128.5 (2×C), 
128.6, 129.1 (2×C), 134.9, 138.7, 150.3 (Ar-C), 175.2 (C=O). IR (KBr, cm
-1
): C=O = 1739. 
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MS (ES+) m/z (%): 323 (M+H
+
, 50), 345 (M+Na
+
, 100). Anal. Calcd for C20H22N2O2: C, 
74.51; H, 6.88; N, 8.69. Found: C, 74.03; H, 7.13; N, 8.75.  
 
4.4. General procedure for the preparation of 1-alkoxy-2-methoxy-9,9,9a-trimethyl-9,9a-
dihydro-1H-imidazo[1,2-a]indoles (7) 
 
n-BuLi (1.25 mL, 1.25 mmol, 2.5 M in cyclohexane) was added dropwise to a solution of 
appropriate 1-alkoxyimidazo[1,2-a]indole 6 (1 mmol) in dry THF (5 mL) under argon at -
78 °C. After 1 h a solution of methyl iodide (170 mg, 1.2 mmol) in dry THF (2 mL) was 
added dropwise over 0.5 h. The mixture was stirred at -78 °C for 1 h and then left to reach 
ambient temperature. The reaction mixture was quenched with 15 mL of ammonium chloride 
solution (10%) and extracted with EtOAc (3×10 mL). The combined organic layers were 
washed with water (15 mL), dried over Na2SO4 and the solvent was evaporated under reduced 
pressure. The residue was chromatographed on a silica gel column with hexane/EtOAc (2:1 
v/v) as eluent to yield compounds 7a-c. 
 
4.4.1. 1,2-Dimethoxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indole (7a)  
Yield 54%. Oil. 
1
H NMR (300 MHz, CDCl3): δ 0.93 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.50 (s, 
3H, CH3), 2.98 (s, 3H, OCH3), 3.47 (s, 3H, OCH3), 4.98 (s, 1H, NCH), 6.92-7.20 (m, 4H, Ar-
H). 
13
C NMR (75 MHz, CDCl3): δ 21.7 (CH3), 22.6 (CH3), 27.2 (CH3), 28.7 (CH3), 49.1 (C-9), 
52.5 (CH3), 88.9 (C-3), 91.2 (C-9a), 113.9, 122.0, 123.0, 128.4, 141.5, 145.5, 167.9 (Ar-C, C-
2). IR (KBr, cm
-1
): C=C(OMe) = 1715. MS (ES+) m/z (%): 283 (M+Na
+
, 100). Anal. Calcd for 
C15H20N2O2: C, 69.20; H, 7.74; N, 10.76. Found: C, 68.97; H, 7.82; N, 11.04. 
 
4.4.2. 1-Ethoxy-2-methoxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indole (7b) 
Yield 58%. Oil. 
1
H NMR (300 MHz, CDCl3): δ 0.94 (s, 3H, CH3), 1.32 (t, J=7.0 Hz, 3H, 
CH2CH3), 1.46 (s, 3H, CH3), 1.49 (s, 3H, CH3), 2.97 (s, 3H, OCH3), 3.65 (dq, J=8.7 Hz, J=7.0 
Hz, 1H, OCH2), 3.84 (dq, J=8.7, J=7.0 Hz, 1H, OCH2), 5.0 (s, 1H, NCH), 6.91-7.20 (m, 4H, 
Ar-H). 
13
C NMR (75 MHz, CDCl3): δ 15.2 (CH3), 21.8 (CH3), 22.6 (CH3), 27.2 (CH3), 28.6 
(CH3), 49.1 (C-9), 61.1 (OCH2), 88.9 (C-3), 90.5 (C-9a), 113.7, 122.0, 122.9, 128.3, 141.4, 
145.6  168.3 (Ar-C, C-2). IR (KBr, cm
-1
): C=C(OMe) = 1715. MS (ES+) m/z (%): 297 (M+Na
+
, 
95). Anal. Calcd for C16H22N2O2: C, 70.04; H, 8.08; N, 10.21. Found: C, 69.89; H, 7.76; N, 
10.13. 
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4.4.3. 1-Benzyloxy-2-methoxy-9,9,9a-trimethyl-9,9a-dihydro-1H-imidazo[1,2-a]indole (7c) 
Yield 63%. Oil. 
1
H NMR (300 MHz, CDCl3): δ 0.97 (s, 3H, CH3), 1.49 (s, 3H, CH3), 1.55 (s, 
3H, CH3), 3.02 (s, 3H, OCH3), 4.65 (d, J=11.1 Hz, 1H, OCH2), 4.86 (d, J=11.1 Hz, 1H, 
OCH2), 5.16 (s, 1H, NCH), 6.88-7.49 (m, 9H, Ar-H). 
13
C NMR (75 MHz, CDCl3): δ 21.9 
(CH3), 22.7 (CH3), 27.3 (CH3), 28.6 (CH3), 49.1 (C-9), 67.2 (OCH2), 89.1 (C-3), 90.2 (C-9a), 
113.9, 122.1, 123.0, 126.9, 127.6, 128.2 (2×C), 128.3, 128.4, 137.7, 141.4, 145.5, 168.1 (Ar-C, 
C-2). IR (KBr, cm
-1
): C=C(OMe) = 1713. MS (ES+) m/z (%): 359 (M+Na
+
, 100). Anal. Calcd 
for C21H24N2O2: C, 74.97; H, 7.19; N, 8.33. Found: C, 74.40; H, 7.33; N, 8.35. 
 
4.5. Procedure for the preparation of 1-[2-(hydroxyamino)-2-oxoethyl]-2,3,3-trimethyl-
3H-indolium perchlorate (8a) 
 
To a solution of compound 3a (232 mg, 1 mmol) in ethanol (3 mL), 60% perchloric acid was 
added dropwise to pH 2 and the solution was kept at 5 °C for 16 h. The precipitated 
crystalline material was filtered, washed with cold ethanol (1 mL) and recrystallized from 
ethanol, to give perchlorate 8a (213 mg, 64%), mp 192-195 °C (from EtOH, with 
decomposition). 
1
H NMR (300 MHz, TFA-d): δ 1.69 (s, 6H, 3,3-CH3, major and minor 
isomers), 2.86 (s, 3H, 2-CH3, minor isomer), 2.90 (s, 3H, 2-CH3, major isomer), 5.49 (s, 2H, 
CH2, major isomer), 5.78 (s, 2H, CH2, minor isomer), 7.59-7.70 (m, 4H, major and minor 
isomers). 
13
C NMR (75 MHz, TFA-d), mixture of isomers:
 δ 15.50, 15.60, 23.84, 49.23, 49.44, 
57.66, 57.69, 116.33, 116.42, 116.5, 125.30, 131.90, 131.94, 133.01, 133.08, 142.97, 143.22, 
143.30, 164.82, 203.39, 203.43. IR (KBr, cm
-1
): OH, NH = 3310, 3271, 3212, C=O = 1690, 
ClO4 = 1111, 1098. Anal. Calcd. for C13H17ClN2O6: C, 46.93; H, 5.15; N, 8.42. Found: C, 
46.84; H, 5.06; N, 8.28.  
 
4.6. Procedure for the preparation of 1-carboxymethyl-2,3,3-trimethyl-3H-indolium 
tetrafluoroborate monohydrate (11) 
 
To a solution of compound 3a (232 mg, 1 mmol) in ethanol (3 mL), tetrafluoroboric acid 
(48%) was added dropwise to pH 2 and the solution was kept at 5 °C for 24 h. The 
precipitated crystalline material was filtered, washed with cold ethanol (1 mL) and 
recrystallized from ethanol, to give tetrafluoroborate 11 (172 mg, 53%), mp 195-197 °C (from 
EtOH). 
1
H NMR (300 MHz, TFA-d): δ 1.85 (s, 6H, 2×3-CH3), 3.04 (s, 3H, 2-CH3), 5.67 (s, 
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2H, CH2), 7.80-7.87 (m, 4H, Ar-H). 
13
C NMR (75 MHz, TFA-d): δ 15.5 (2-CH3), 23.9 (2×3-
CH3), 50.2 (C-3), 57.9 (CH2), 116.3, 125.6, 132.1, 133.4, 143.0, 143.5 (Ar-C), 170.9 (CO2H), 
203.3 (N
+
=C). IR (KBr, cm
-1
): OH = 3436, C=O = 1634, BF4 = 1053, 768. Anal. Calcd. for 
C13H16BF4NO2
.
H2O: C, 48.33; H, 5.62; N, 4.34. Found: C, 47.93; H, 5.46; N, 4.67. 
 
 
4.7. Procedure for the preparation of N-hydroxy-2-(2,3,3-trimethyl-2,3-dihydro-1H-
indol-1-yl)acetamide (12) 
 
To a solution of compound 3a (200 mg, 0.8 mmol) in glacial acetic acid (2 mL), sodium 
borohydride (98.8 mg, 2.6 mmol) was added in portions and the mixture was stirred at 
ambient temperature for 3 h. The reaction mixture was poured into water (5 mL), the solution 
was neutralized with sodium carbonate to pH 9 and extracted with Et2O (3×5 mL). The 
combined organic extracts were washed with brine (3 mL), dried over Na2SO4 and filtered. 
The solvent was evaporated under reduced pressure and the residue was chromatographed on 
a silica gel column with hexane/EtOAc (1:1 v/v) as eluent to yield compound 12 (165 mg, 
88 %) as white crystals, mp 119-120 °C. 
1
H NMR (300 MHz, CDCl3): δ 1.11 (s, 3H, 3-CH3), 
1.26 (d, J=6.6 Hz, 3H, CHCH3), 1.35 (s, 3H, 3-CH3), 3.15 (q, J=6.6 Hz, CHCH3), 3.74 (s, 
CH2), 6.50-7.17 (4H, m, Ar-H), 9.21 (br. s, 1H, NH or OH), 9.46 (br. s, NH or OH). 
13
C NMR 
(75 MHz, CDCl3): δ 12.9 (CH3), 23.5 (CH3), 25.8 (CH3), 43.1 (C-3), 51.9 (CH2), 72.2 (C-2), 
108.4, 120.8, 122.4, 127.9, 139.5, 150.2, 168.6 (C=O). IR (KBr, cm
-1
): OH, NH = 3203, C=O = 
1656. MS (ES+) m/z (%): 257 (M+Na
+
, 60). Anal. Calcd. for C13H18N2O2: C, 66.64; H, 7.74; 
N, 11.96. Found: C, 66.86; H, 7.77; N, 11.53. 
 
4.8. Procedure for the preparation of 1,3,9,9,9a-pentamethyl-9,9a-dihydro-1H-
imidazo[1,2-a]indol-2(3H)-one (15) 
  
n-BuLi (3 mL, 4.8 mmol, 1.6 M in hexane) was added to a solution of compound 13 (920 mg, 
4 mmol) in THF (13 mL) under argon at -78 °C. After stirring for 1 h, a solution of methyl 
iodide (681 mg, 4.8 mmol) in dry THF (8 mL) was added dropwise over 20 min, and the 
mixture allowed to reach ambient temperature. After 3 h, the reaction mixture was quenched 
with a ammonium chloride solution (10%, 25 mL) and extracted with EtOAc (2×15 mL). The 
combined organic extracts were washed with water (15 mL), dried over Na2SO4, filtered and 
the solvent was evaporated under reduced pressure. The residue was chromatographed on a 
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silica gel column with hexane/EtOAc (9:1 v/v) as eluent to give compound 15 (495 mg, 51%) 
as colourless oil. 
 1
H NMR (300 MHz, CDCl3): δ 1.01 (s, 3H, CH3), 1.426 (s, 3H, CH3), 1.429 
(s, 3H, CH3), 1.56 (d, J=6.9 Hz, 3H, CH3), 2.95 (s, 3H, CH3), 3.78 (q, J=6.9 Hz, 1H, CHCH3), 
6.82-7.18 (m, 4H, Ar-H). 
13
C NMR (75 MHz, CDCl3): δ 21.6, 22.2, 24.1, 27.2, 29.4, 49.5, 
61.2, 89.4 (9a-C), 113.9, 122.2, 122.4, 128.2, 141.6, 148.4 (Ar-C), 173.3. 
15
N NMR (50.69 
MHz, CDCl3): δ -257.1 (N-1), -289.1 (N-4). IR (KBr, cm
-1
): C=O = 1699. Anal. Calcd. for 
C15H20N2O: C, 73.74; H, 8.25; N, 11.47. Found: C 73.51; H 8.15; N 11.68. 
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